3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
11
Brain Neoplasms
3
Recurrence
2
Osteosarcoma
2
Multiple Myeloma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Glioma
2
Glioblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Xanthomatosis, Cerebrotendinous
1
Vaccinia
1
Uveal Melanoma
1
Transplant-Related Hematologic Malignancy
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Resectable Esophageal Cancer
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Oligodendroglioma
1
Neoplasms
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Interventions
pembrolizumab
91
Carboplatin
80
Specimen Handling
77
Magnetic Resonance Spectroscopy
64
Pemetrexed
62
Cisplatin
49
durvalumab
45
Paclitaxel
40
Nivolumab
35
atezolizumab
31
Radiotherapy
30
osimertinib
29
Radiosurgery
29
Blood Specimen Collection
27
Biopsy
26
Immunoglobulin G
24
Gemcitabine
24
Docetaxel
24
Disulfides
23
Standard of Care
22
Drug Therapy
21
Taxes
20
Etoposide
20
Practice Guidelines as Topic
18
Radiation
17
Educational Status
16
X-Rays
15
130-nm albumin-bound paclitaxel
15
Surveys and Questionnaires
14
Bevacizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
1 year
×
Clear all
No trials found.